MARKET

ZLDAF

ZLDAF

Zelira Therapeutics Limited
OTCMQB

Real-time Quotes | Nasdaq Last Sale

1.500
0.000
0.00%
Closed 16:00 08/10 EDT
OPEN
--
PREV CLOSE
1.500
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
2.090
52 WEEK LOW
0.012
MARKET CAP
14.37M
P/E (TTM)
-1.3717
1D
5D
1M
3M
1Y
5Y
Zelira's Zenivol, Clinically Validated Cannabinoid Medication For Insomnia, Gets Regulatory Approval In Germany
Zelira Therapeutics Ltd’s (OTCQB: ZLDAF) (ASX:ZLD) insomnia medication Zenivol has achieved formal approval from German regulatory authority BfArM to launch in the German medical cannabis market.
Benzinga · 07/22 12:28
Zelira's Zenivol™, the World's First Clinically Validated Cannabinoid Medication for Insomnia, Achieves Regulatory Approval in Germany
Zelira Therapeutics Ltd (ASX: ZLD, OTC-QB: ZLDAF), a global leader in the research, development and commercialization of clinically validated cannabinoid medicines, is pleased to announce that its groundbreaking insomnia medication Zenivol™ has achieved fo...
PR Newswire · 07/21 16:42
We're Keeping An Eye On Zelira Therapeutics' (ASX:ZLD) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Simply Wall St. · 07/14 21:49
The Best Cannabis Conference In Latin America Arrives In Panama: Join LATAM CANN.BIZ On Sep. 1 & 2, Get Business Done
LatAm Cann.BIZ, the most important cannabis event in Latin America, will be held, on September 1 and 2, at the Santa María Luxury Collection Hotel & Golf Resort in Panama City.
Benzinga · 07/14 15:37
Cannabis Goes Head-to-Head With Big Pharma In New Zelira Therapeutics Pain Med Study
Zelira Therapeutics (OTC: ZLDAF), a global leader in the research, development and commercialization of clinically validated cannabinoid medicines, is about to begin the first-ever clinical trial of its own proprietary product for the treatment of diabetic...
Benzinga · 06/09 16:58
Despite Underrepresentation, Black Leaders Are Impacting Every Part Of Cannabis
The history of cannabis in the United States is marked by the exclusion and persecution of people of color, particularly Black Americans. Cannabis prohibition, along with institutional racism, have led to bar many Black people from entry into this multi-bi...
Benzinga · 02/28 20:50
EXCLUSIVE: Cannabis Co. Zelira Therapeutics Acquires Health House International
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF) is acquiring Health House International Limited (ASX: HHI), Benzinga has learned exclusively.
Benzinga · 02/28 19:05
Zelira Therapeutics (ASX:ZLD) Will Have To Spend Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Simply Wall St. · 12/27/2021 04:31
More
No Data
Learn about the latest financial forecast of ZLDAF. Analyze the recent business situations of Zelira Therapeutics Limited through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

100.00%Strong Buy
0.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ZLDAF stock price target is 9.22 with a high estimate of 10.16 and a low estimate of 8.28.
High10.16
Average9.22
Low8.28
Current 1.500
EPS
Actual
Estimate
-0.51-0.38-0.26-0.13
  • 0
2020/06
2021/12
2021/06
2022/12
    0
2022/06
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+3.06%
Pharmaceuticals & Medical Research
+0.92%
Key Executives
Chairman/Director
Osagie Imasogie
Managing Director
Oludare Odumosu
Secretary/Non-Executive Director
Timothy Slate
Director
Lisa Gray
Non-Executive Director
Leon Davies
No Data
No Data
About ZLDAF
Zelira Therapeutics Ltd, formerly Zelda Therapeutics Ltd, is an Australia-based therapeutic medicinal cannabis company. The company is focused on developing cannabis products for the treatment of a variety of medical conditions. It is focused on human clinical trial programs focused on insomnia, autism and opioid reduction with activities in Australia and the United States. It is also focused on pre-clinical research examining the effect of cannabinoids in breast, brain and pancreatic cancer, as well as research and development of cannabinoids to treat diabetes-associated cognitive decline. It develops treatments based on plant-derived medicinal cannabis products.

Webull offers kinds of Zelira Therapeutics Ltd stock information, including OTCMQB:ZLDAF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZLDAF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ZLDAF stock methods without spending real money on the virtual paper trading platform.